Cargando…

Ophthalmologic manifestations in patients with inflammatory bowel disease

BACKGROUND/AIMS: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), has been reported to have various ophthalmologic manifestations. The aim of this study was to evaluate the prevalence of ophthalmologic manifestations associated with IBD in Korea. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye Jin, Song, Hyun Joo, Jeong, Jin Ho, Kim, Heung Up, Boo, Sun-Jin, Na, Soo-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478763/
https://www.ncbi.nlm.nih.gov/pubmed/28670235
http://dx.doi.org/10.5217/ir.2017.15.3.380
_version_ 1783245018877657088
author Lee, Hye Jin
Song, Hyun Joo
Jeong, Jin Ho
Kim, Heung Up
Boo, Sun-Jin
Na, Soo-Young
author_facet Lee, Hye Jin
Song, Hyun Joo
Jeong, Jin Ho
Kim, Heung Up
Boo, Sun-Jin
Na, Soo-Young
author_sort Lee, Hye Jin
collection PubMed
description BACKGROUND/AIMS: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), has been reported to have various ophthalmologic manifestations. The aim of this study was to evaluate the prevalence of ophthalmologic manifestations associated with IBD in Korea. METHODS: Sixty-one patients were examined between May 2013 and October 2014. We performed complete ophthalmologic examinations. RESULTS: Findings included 36 patients with CD and 25 with UC. The mean age of the patients was 34±16 years and disease duration was 45.3±23.9 months. Ophthalmologic manifestations were positive in 44 cases. Primary complication was diagnosed in 5 cases, as follows; iritis in 2 cases, episcleritis in one case, iritis with optic neuritis in 1 case, and serous retinal detachment in 1 case, without secondary complications. The most common coincidental complication was dry eye syndrome (DES), in 35 patients (57.4%). The prevalence of DES in the control group was 21.3%. The proportion of DES in patients with IBD was significantly higher than in the control group (P=0.002). CONCLUSIONS: Ophthalmologic manifestations were high (72.1%) in IBD patients. Clinically significant primary ocular inflammation occurred in 8.2% of patients. The most common complication was DES. There was a higher rate of DES in patients with IBD compared to the control group. Evaluation of the eye should be a routine component in patients with IBD.
format Online
Article
Text
id pubmed-5478763
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Korean Association for the Study of Intestinal Diseases
record_format MEDLINE/PubMed
spelling pubmed-54787632017-07-01 Ophthalmologic manifestations in patients with inflammatory bowel disease Lee, Hye Jin Song, Hyun Joo Jeong, Jin Ho Kim, Heung Up Boo, Sun-Jin Na, Soo-Young Intest Res Original Article BACKGROUND/AIMS: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), has been reported to have various ophthalmologic manifestations. The aim of this study was to evaluate the prevalence of ophthalmologic manifestations associated with IBD in Korea. METHODS: Sixty-one patients were examined between May 2013 and October 2014. We performed complete ophthalmologic examinations. RESULTS: Findings included 36 patients with CD and 25 with UC. The mean age of the patients was 34±16 years and disease duration was 45.3±23.9 months. Ophthalmologic manifestations were positive in 44 cases. Primary complication was diagnosed in 5 cases, as follows; iritis in 2 cases, episcleritis in one case, iritis with optic neuritis in 1 case, and serous retinal detachment in 1 case, without secondary complications. The most common coincidental complication was dry eye syndrome (DES), in 35 patients (57.4%). The prevalence of DES in the control group was 21.3%. The proportion of DES in patients with IBD was significantly higher than in the control group (P=0.002). CONCLUSIONS: Ophthalmologic manifestations were high (72.1%) in IBD patients. Clinically significant primary ocular inflammation occurred in 8.2% of patients. The most common complication was DES. There was a higher rate of DES in patients with IBD compared to the control group. Evaluation of the eye should be a routine component in patients with IBD. Korean Association for the Study of Intestinal Diseases 2017-07 2017-06-12 /pmc/articles/PMC5478763/ /pubmed/28670235 http://dx.doi.org/10.5217/ir.2017.15.3.380 Text en © Copyright 2017. Korean Association for the Study of Intestinal Diseases. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Hye Jin
Song, Hyun Joo
Jeong, Jin Ho
Kim, Heung Up
Boo, Sun-Jin
Na, Soo-Young
Ophthalmologic manifestations in patients with inflammatory bowel disease
title Ophthalmologic manifestations in patients with inflammatory bowel disease
title_full Ophthalmologic manifestations in patients with inflammatory bowel disease
title_fullStr Ophthalmologic manifestations in patients with inflammatory bowel disease
title_full_unstemmed Ophthalmologic manifestations in patients with inflammatory bowel disease
title_short Ophthalmologic manifestations in patients with inflammatory bowel disease
title_sort ophthalmologic manifestations in patients with inflammatory bowel disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478763/
https://www.ncbi.nlm.nih.gov/pubmed/28670235
http://dx.doi.org/10.5217/ir.2017.15.3.380
work_keys_str_mv AT leehyejin ophthalmologicmanifestationsinpatientswithinflammatoryboweldisease
AT songhyunjoo ophthalmologicmanifestationsinpatientswithinflammatoryboweldisease
AT jeongjinho ophthalmologicmanifestationsinpatientswithinflammatoryboweldisease
AT kimheungup ophthalmologicmanifestationsinpatientswithinflammatoryboweldisease
AT boosunjin ophthalmologicmanifestationsinpatientswithinflammatoryboweldisease
AT nasooyoung ophthalmologicmanifestationsinpatientswithinflammatoryboweldisease